#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Mutagenic effect of advanced paternal age in neurocardiofaciocutaneous syndrome


Authors: prof. MUDr. Eva Seemanová, DrSc. 1;  Martin Zenker 2
Authors‘ workplace: Oddělení klinické genetiky, Ústav biologie a lékařské genetiky 2. LF UK, Praha 1;  Institut für Humangenetik der Technischen Hochschule, Magdeburg, SRN 2
Published in: Čas. Lék. čes. 2014; 153: 242-245
Category: Original Article

Overview

Background.
Increased frequency of chromosomal aberration in children of mothers aged 35 years and older is very well known and since 1973 it is an indication to investigate the foetal karyotype in cells obtained by invasive method (amniocentesis), because the genetic risk of severe affection is higher than the risk of necessary invasive method. Mutagenic effect of advanced paternal age is known only among geneticists (1–4). The reason is not only low absolute risk of new mutation but particularly a high number of involved genes and last not least the limited spectrum of autosomal dominant disorders without abiotrofic character. Therefore the preventive methods for elimination of this risk are very limited. Only a few of them could be recognized prenatally by noninvasive methods of prenatal diagnostics.

Methods.
Genealogical, anamnestic and clinical data of 83 patients were studied with clinical suspection on neurocardiofaciocutaneous syndrome (NCFCs) (5–7). The diagnosis has not been confirmed in 29 patients, no mutation was detected in 8 investigated genes (PTPN11, SOS1, HRAS, BRAF, RAF1, MEK1, KRAS, NRAS). In 54 patients with autosomal dominant inherited Noonan syndrome, Costello syndrome and cardiofaciocutaneous syndrome the diagnosis was confirmed on DNA level and the biological fitness was estimated for each disorder. Paternal age at conception was compared in the group of patients with familial and sporadic occurrence of Noonan and NCFC syndromes. The clinical prognosis of this disorder is represented by biological fitness of patients. Coefficient of selection is 0,6 in Noonan and LEOPARD syndromes (29 from 48). All 6 patients with Costello and cardiofaciocutaneous syndromes developed due to a new mutation.

Conclusion.
Paternal age at birth was studied in 83 children patients with autosomal dominant Neurocardiofaciocutaneous syndrome (Noonan, LEOPARD, Costello, CFC) with a high population incidence and decreased biological fitness. Due to severe congenital heart defects, failure to thrive in infancy, increased risk for malignancy and further health problems the clinical prognosis of patients in the past was not good. Therefore high mutation rate is expected until now. Identification of genes responsible for manifestation of this disorder, enables to confirm the diagnosis and to recognize inherited and de novo mutations. Genealogy and DNA analysis of PTPN11, SOS1, HRAS, BRAF, RAF1, MEK1, KRAS and NRAS were obtained in cohort of 54 patients with NCFC syndromes and their parents. There were 48 patients with Noonan and LEOPARD syndromes, in 29 cases due to mutation de novo, 19 patients inherited the mutation from one of parents. All 6 patients with Costello syndrome and CFC syndrome were affected due to new mutation. DNA analysis revealed 32 mutations in PTPN11 gene, mutation in SOS1 gene was found in 10 patients, RAF1 mutation was present in 3 patients; mutation in MEK1, KRAS and NRAS genes was present in one patient each. In Costello syndrome and CFC syndrome mutations in HRAS (4 patients) and BRAF (2 patients) genes were detected. Genealogic data allow analysing parental age in the group of patients with new mutation and inherited mutation. Paternal age at conception of patients with Noonan syndrome due to new mutation was significantly increased in comparison to the group of fathers of Noonan patients with inherited mutation – 38,4 years and 29,6 years, resp., range 28 to 55 years and 25 to 35 years, resp. Maternal age was slightly increased too, –30,9 and 27,7, resp. and range 24 to 42 years and 21 to 36 years, resp. but not significantly. The results support the mutagenic effect of paternal age, espec. autosomal dominant mutations.

Keywords:
advanced parental age – mutagenic effect – chromosomal mutations – gene mutations – manifestation of new mutations – coefficient of selection – mutation rate


Sources

1. de la Rochebrochard E, Thonneau P. Paternal age and maternal age are factors for miscarriage, results of a multicentre European study. Hu Reprod 2002; 17(6): 1649–1656.

2. Wiener-Megnazi Z, Auslender R, Dirnfeld M. Advanced paternal age and reproductive outcome. Asian J Androl 2012; 14(1): 69–76.

3. Balasch J, Gratacos E. Delayed childbearing: effects on fertility and the outcome of pregnancy. Curr Opin Obstet Gynecol 2012; 24(3): 187–193.

4. Alio AP, Salihu HM, McIntosh C, August EM, Weldeselasse H, Sanchez E, Mbah AK. The effect of paternal age on fetal birth outcomes. Am J. Mens Health 2012; 6(5): 427–435.

5. Noonan JA, Elinke DA. Associated noncardiac malformations in children with congenital heart disease. J Pediatr 1963; 63: 469–474.

6. http://OMIM org/entry

7. Ferrezo GB, Baldassarre G, Delmonaco AG, Biamano E, Bananda E, Carta C, Rossi C, Silengo MC. Clinical and molecular characterization of 40 patinets with Noonan syndrome. Eur J Med. Genet 2008; 51(6): 566–572.

8. Ezguieta B, Santorné JL, Carcavillo A, Guillen-Navarro E, Perez-Aytes A, Sanchez del Pozo J, Garcia-Minaur S, Castillo E, Alonso M, Vendrell T, Santoria A, Maroto E, Gallus L. Alterations in RAS-MAPK genes in 200 spanish patients with Noonan and other neuro-cardio-facio-cutaneous syndromes. Genotype and cardiopathy. Rev Esp Cardiol 2012; 65(5): 447–455.

9. Schulz AL, Albrecht B, Arici C, van der Burgt I, Buske A, Gillessen-Kaesbach G, Helter R, Horn D., Hübner CA, Korenke GC, König R, Kress W, Krüger G, Meinecke P, Mücke J, Plecko B, Rossler E, Schinzel A, Schultze A, Seemanová E, Seidel H, Spranger S, Tuysuz B, Uhring S, Wieczorek D, Kutsche K, Zenker M. Mutation and phenotypic spectrum in patients with cardio-facio-cutaneous and Costello syndromes. Clin Genet 2007; 73(1): 62–70.

10. Cristea IC, Kutsche K, Dvorsky R, Gremer L, Carta C, Horn D, Roberts A-E, Lepri F, Merblitz-Zahradnik T, König R, Kratz CP, Panta-leoni F, Dentici ML, Joski VA, Kucherlapati RS, Mazzanti L, Mundlos S, Patton MA, Silengo MC, Rossi C, Zampino G, Digillo C, Stuppia L, Seemanová E, Pennacchio LA, Gelb BD, Dallapiccola B, Wittinghofer A, Ahmadian MR, Tartaglia M, Zenker M. A restricted spectrum of NRAS mutations causes Noonan syndrome. Nat Genet 2010; 42(1) 27–29.

Labels
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental Hygienist
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#